IncFact
Company Profiles: Revenue, Growth, Competition

VIACYTE Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Viacyte

Access the complete profile.

Viacyte Fast Facts

RevenueN/A    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry5417 Scientific Research & Development Services
Address3550 General Atomics Ct.
#2-503
San Diego, CA 92121

www.viacyte.com
Note: Revenues for privately held companies are statistical evaluations.


(see exact revenue data). It is classified as operating in the Scientific Research & Development Services industry.


Viacyte's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?


Investor Activity

Viacyte has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
December 3, 2018 9 40%$90 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Viacyte is developing and marketing. Viacyte doesn't have any recent trademark applications, indicating Viacyte is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
REGENERATING HEALTH
Cells for scientific, laboratory or medical research
09/19/2013
ENCAPTRA
Drug delivery systems
04/22/2010
VIACYTE
Scientific research and development for medical and pharmaceutical purposes; scientific research and development related to human diseases and disorders
02/12/2010

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Viacyte grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Viacyte is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Viacyte's Largest Competitors

A competitive analysis shows these companies are in the same general field as Viacyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SRI INTERNATIONALMenlo Park, CA100 
COLD SPRING HARBOR LABORATORYCold Spring Harbor, NY47 
QUINTILESDurham, NC14 
SYNEOS HEALTHRaleigh, NC8 
ALEXION PHARMACEUTICALSNew Haven, CT7 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM6 
LEIDOSReston, VA6 
BECHTEL MARINE PROPULSIONWest Mifflin, PA6 
SOUTHERN RESEARCH INSTITUTEBirmingham, AL5 




Nearby Competitors

These companies are similar in business line and location to Viacyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ILLUMINASan Diego, CA100 
NEUROCRINE BIOSCIENCESSan Diego, CA11 
SAMUMEDSan Diego, CA10 
LIGAND PHARMACEUTICALSSan Diego, CA9 
ACADIA PHARMACEUTICALSSan Diego, CA8 
RETROPHINSan Diego, CA6 




Future Competition: Viacyte's Fastest Growing Competitors

These companies are in the same general field as Viacyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Viacyte Competitors